CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
Life Sciences Review
US
EUROPE
APAC
CANADA

About Us

Conference

Partner With Us

  • US
    • EUROPE
    • APAC
    • CANADA
    • LATAM
  • Drug Discovery
    Antibodies
    BioTech
    Cell and Gene Therapy
    Clinical Trial
    Drug Discovery and Development
    Life Science AI
    Regenerative Medicine
    Therapeutics
  • Biomanufacturing
    Biomanufacturing
    Bioprocessing
    Blood Bank
    CDMO
    Clinical Laboratory
    CRO
    Life Science Testing
    Skin Care
    Supplements
  • Business Services
    Life Science Consulting
    Life Science Facility Service
    Life Science Financial Services
    Life Science Marketing
    Life Science Recruitment Firms
    Pharma Wholesale and Distribution
    Pharmacy Management
    Regulatory and Compliance
    Regulatory Services
  • Leadership Perspectives
  • Innovation Insights
  • Research
  • News
  • Magazines
  • CXO Awards
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading

Thank you for Subscribing to Life Science Review Weekly Brief

  • Home
  • Therapeutics
  • Top Therapeutics Companies in APAC

Therapeutics 2024

Top 10 Therapeutics Companies in APAC - 2024

Top 10 Therapeutics Companies in APAC - 2024

With the therapeutics landscape gaining traction in recent years and promising to reshape the future of personalized medicine, one key trend is gene therapy and CRISPR technology. It is transforming how we address genetic disorders. Gene therapy can potentially correct genetic mutations at their source, providing lasting relief or even curing for incurable conditions. Meanwhile, CRISPR allows scientists to precisely modify DNA, offering new possibilities for treating diseases like muscular dystrophy and even certain cancers.

Another transformative trend is the rise of microbiome-based therapies, which leverage the body’s natural microbial ecosystem to enhance health and treat disease. Recent therapeutic strategies focus on restoring or modifying the microbiome to treat conditions such as inflammatory bowel disease (IBD), obesity and even neurodegenerative diseases. This area is rapidly evolving, with therapies aimed at rebalancing gut flora and other microbial communities to promote long-term health.

Driven by these trends, the global therapeutics market is projected to reach $155.20 billion by the end of 2034, growing at a CAGR of 6.83 percent.

This edition of the Life Sciences Review APAC offers insights into the latest developments in therapeutic treatment and how companies align with these trends.

The magazine features a thought-provoking article from James Riddle, Senior Vice President - Global Review Operations at Advarra. He highlights the importance of the significant advancements and future potential of immunotherapy and its applications beyond oncology. The article by Clement Lim, Director, Head of Early Cancer Detection, Scientific & Medical Affairs at Mirxes, provides a comprehensive overview of the evolving field of immunotherapy, with the promise of further breakthroughs through personalized medicine and ongoing research.

We also bring you top therapeutics companies that provide cutting-edge products and solutions. A noteworthy story is that of HiST Pharma. This wellestablished, company specializes in developing botanical-based drugs that integrate Traditional Chinese Medicine (TCM) with modern medical science. It uses a reverse drug discovery process, leveraging the efficacy and safety of plant-based compounds to create innovative treatments.

In this edition featuring the Top Therapeutics Companies in APAC 2024, we hope you find the right partner to meet your organization’s needs.

Top 10 Therapeutics Companies in APAC - 2024

Nominate a Company

Usually, the qualified subscribers of our magazine nominate companies with whom they have collaborated and experienced exceptional results to be in this list. Did a company you recently worked with give you stellar results and ROI? Did it turn out to be one you would wholeheartedly recommend to peers? Or do you know of such an outstanding company through your network? Please fill in the details below and nominate them to be featured here.

* 

captcha
Can't read the image? click here to refresh

Thank You!

checkmark

We are glad to receive your nomination. Our editorial team and evaluation panel will review your submission. Thank you for taking the time to highlight an organization driving impactful change in Lifescience Review.

Data not inserted

    Top Therapeutics Companies in APAC

    ★Featured Companies
    HiST Pharma
    HiST Pharma
    Read full profile →
    HiST Pharma, founded by Prof. Dr. Liping Yang, pioneers botanical-based drugs for psoriasis and immune-mediated skin diseases. Their flagship product, TC Cream, is a topical botanical drug derived from natural plants, addressing psoriasis globally. Employing a reverse drug discovery process, they integrate Traditional Chinese Medicine principles with modern technology, ensuring efficacy and safety through evidence-based research. This innovative approach accelerates drug development, offering a holistic solution for immune-mediated skin diseases. ... read full profile
    Shanghai Yuansong Biotechnology
    Shanghai Yuansong Biotechnology
    Read full profile →
    Shanghai Yuansong Biotechnology was founded by a team of academicians with a primary focus on the research and development of targeted biotherapeutic drugs for cancer treatment. The company boasts strong capabilities in new product development and remains dedicated to advancing its work to make significant contributions to human health. ... read full profile
    HiFiBiO Therapeutics
    HiFiBiO Therapeutics
    HiFiBiO Therapeutics is a clinical-stage biotechnology company focused on advancing transformative immunotherapies for cancer and autoimmune diseases. Utilizing its proprietary Drug Intelligence Science (DIS®) platform, HiFiBiO accelerates the discovery of novel antibody drugs and predictive biomarkers. The company leverages single-cell analysis and AI/ML to enhance treatment precision and success rates.
    HuidaGene Therapeutics
    HuidaGene Therapeutics
    HuidaGene Therapeutics is a global clinical-stage biotechnology company focused on developing cutting-edge gene editing tools and therapies to treat genetic disorders. Their proprietary platforms, including CRISPR-based technologies, target conditions in neurology, ophthalmology, and neuromuscular diseases, offering innovative treatments to patients worldwide.
    LTR Pharma
    LTR Pharma
    LTR Pharma is a clinical-stage pharmaceutical company focused on commercializing SPONTAN®, a rapid-acting intranasal spray for treating erectile dysfunction (ED). Designed to bypass the digestive system, SPONTAN® offers a faster onset of action compared to traditional oral tablets, providing a more convenient and efficient treatment alternative.
    Neurophth Therapeutics
    Neurophth Therapeutics
    Neurophth Therapeutics is an innovative gene therapy company specializing in the treatment of ocular diseases such as Leber Hereditary Optic Neuropathy (LHON). Utilizing AAV-based gene therapy platforms, Neurophth is advancing a robust pipeline aimed at restoring vision and addressing critical unmet medical needs in ophthalmology
    Protagonist Therapeutics
    Protagonist Therapeutics
    Protagonist Therapeutics focuses on discovering and developing peptide-based therapies to treat diseases with significant unmet medical needs. Their innovative approach includes using oral peptides to target biological pathways, with key candidates in clinical trials for conditions like polycythemia vera and psoriasis. Their commitment to patient-centric innovation drives their clinical programs.
    Rowan
    Rowan
    Rowan is a digital therapeutics company dedicated to enhancing healthcare through artificial intelligence and medical expertise. It develops personalized solutions targeting cognitive impairment and neurological disorders. By harnessing big data, Rowan aims to improve patient outcomes and advance the future of digital health technologies.
    Structure Therapeutics
    Structure Therapeutics
    Structure Therapeutics is a clinical-stage biopharmaceutical company dedicated to developing innovative oral treatments for chronic metabolic and cardiopulmonary conditions with unmet medical needs. Utilizing a structure-based drug discovery platform, they have established a robust pipeline featuring small molecule compounds that aim to overcome the limitations of traditional therapies.
    Y-Biologics
    Y-Biologics
    Y-Biologics is a biopharmaceutical company specializing in the discovery and development of novel antibody therapeutics. The company has developed advanced platforms, including a competitive human antibody library and bispecific antibody formats, with a focus on immunooncology. Their lead candidate, YBL-006, is currently undergoing clinical trials for cancer treatment.
Life Sciences Review
Follow on LinkedIn

About

  • Home
  • About Us
  • Partner With Us

Stay Connected

  • Subscribe
  • Newsletter
  • Sitemap

Contact Us

  • editor@lifesciencesreview.com
  • sales@lifesciencesreview.com
  • marketing@lifesciencesreview.com

Legal

  • Editorial Policy
  • Privacy Policy
  • Terms of Use

© 2026 Life Sciences Review. All rights reserved. Headquartered in Fort Lauderdale, FL, USA.

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://therapeutics-apac.lifesciencesreview.com/vendors/top-therapeutics-companies-in-apac.html